Vaxart
VXRT Micro CapHealthcare · Biotechnology
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Vaxart Stock at a Glance
Vaxart (VXRT) is currently trading at 0,66 € with a market capitalization of 159 M €. The trailing P/E ratio stands at 11x. The 52-week range spans from 0,22 € to 0,72 €; the current price is 8.3% below the yearly high. Year-over-year revenue growth stands at +586.5%. The net profit margin stands at 6.88%.
💰 Dividendo
Vaxart currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
2 analysts rate Vaxart (VXRT) on consensus: None. The average price target is 2,56 €, implying +289.61% from the current price. Analyst price targets range from 1,71 € to 3,41 €.
Tesi di Investimento: Punti di Forza e Debolezze
- Strong revenue growth of 586.5% YoY
- High return on equity (22.26% ROE)
- Currently flagged as undervalued
- Solid balance sheet with low debt (D/E 14.86)
- –Negative free cash flow
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to market-like volatility, elevated short interest (9.4%).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Vaxart?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
